Drug therapy significantly extends lifespan of worms

Using drugs that help eliminate oxygen radicals -- the toxic byproducts of metabolism -- scientists have extended the normal lifespan of the nematode worm C. elegans by approximately 50 percent. In addition, the scientists restored a normal lifespan to mutant worms that had a mitochondrial defect causing increased oxygen radical production and rapid aging. The findings were reported in the September 1, 2000 issue of Science.

The collaborative research was conducted by Simon Melov, Ph.D., of the Buck Center for Research in Aging and formerly of the Center for Molecular Medicine at Emory University; Gordon Lithgow, Ph.D., University of Manchester, UK; Douglas Wallace, Ph.D., director of the Center for Molecular Medicine at Emory University; and Susan Doctrow, Ph.D. and Bernard Malfroy, Ph.D. of Eukarion, Inc., a biopharmaceutical company.

The drugs used in the experiments are synthetic forms of superoxide dismutase and catalase -- enzymes that naturally help control oxidative stress. Although they have an anti-oxidant effect, the compounds are much more powerful than simple anti-oxidants such as vitamin E, which eliminate individual oxygen radical molecules one-on-one and quickly lose their effectiveness. The new synthetic compounds are catalytic drugs that convert oxygen radicals to water, then reconstitute themselves in a cogwheel-like process that continues to destroy additional oxygen radicals as long as the drugs remain in the body.

Since the early 1970s, Dr. Wallace and his colleagues in Emory's Center for Molecular Medicine have been studying mitochondria -- the tiny power plants located in the cytoplasm of cells. Dr. Wallace believes that by demonstrating the effectiveness of these drugs in slowing the aging process, this work supports his long-held hypothesis that oxygen radicals generated in the mitochondria during metabolism are a major cause of degenerative diseases and aging.

As byproducts of energy generation, says Dr. Wal

Contact: Holly Korschun
Emory University Health Sciences Center

Page: 1 2

Related medicine news :

1. Study shows patch therapy may be as effective as oral medications
2. Novel therapy tested in mice could chase away cat allergies
3. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack
4. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
5. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
6. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
7. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
8. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
9. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
10. Cognitive behavioral therapy and medication is effective in the treatment of panic disorder
11. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Post Your Comments:

(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology:
Cached News: